FDA Adverse Event Injury Summary report: N

MECTACER BIOLOX DELTA FEMORAL BALL HEAD

MDR report key: 25297695 · Received May 27, 2026

Report

Report Number
3005180920-2026-00532
Event Type
Injury
Date Received
May 27, 2026
Date of Event
May 14, 2026
Report Date
May 27, 2026
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030809231
PMA / PMN Number
K112115
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 27 MAY 2026: MECTACER 01.29.212 MECTACER HEAD BIOLOX DELTA DIA.40 12/14-S (K112115) LOT. 2528827: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 13-NOV-2025. EXPIRATION DATE: 2030-NOV-02. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. MPACT 01.32.4048HCT FLAT PE HC LINER D 40/F (K122641) LOT. 2526525: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 12-NOV-2025. EXPIRATION DATE: 2030-OCT-21. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ROOT CAUSE: BASED ON THE INFORMATION AVAILABLE NO DEFINITIVE ROOT CAUSE CAN BE ESTABLISHED, WHILE THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT, AND THE DEVICE HISTORY RECORD REVIEW DOES NOT INDICATE ANY POTENTIAL MANUFACTURING RELATED ISSUE.

Description of Event or Problem · 0

REVISION SURGERY DUE TO JOINT LUXATION AFTER 8 DAYS FROM PRIMARY. THE CERAMIC HEAD DISLOCATED FROM THE LINER. THE SURGEON REVISED THE 40MM BIOLOX S HEAD WITH A SAME SIZE HEAD, AND REVISED THE FLAT PE HC D 40/F LINER TO A SAME SIZE LINER. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
289436 MECTACER BIOLOX DELTA FEMORAL BALL HEAD MECTACER HEAD BIOLOX DELTA DIA.40 12/14-S LZO MEDACTA INTERNATIONAL SA 01.29.212 2528827 07630030809231

Patients

Seq Age Sex Outcome Treatment
1